Rifater

WikiDoc Resources for Rifater

Articles

Most recent articles on Rifater

Most cited articles on Rifater

Review articles on Rifater

Articles on Rifater in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Rifater

Images of Rifater

Photos of Rifater

Podcasts & MP3s on Rifater

Videos on Rifater

Evidence Based Medicine

Cochrane Collaboration on Rifater

Bandolier on Rifater

TRIP on Rifater

Clinical Trials

Ongoing Trials on Rifater at Clinical Trials.gov

Trial results on Rifater

Clinical Trials on Rifater at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Rifater

NICE Guidance on Rifater

NHS PRODIGY Guidance

FDA on Rifater

CDC on Rifater

Books

Books on Rifater

News

Rifater in the news

Be alerted to news on Rifater

News trends on Rifater

Commentary

Blogs on Rifater

Definitions

Definitions of Rifater

Patient Resources / Community

Patient resources on Rifater

Discussion groups on Rifater

Patient Handouts on Rifater

Directions to Hospitals Treating Rifater

Risk calculators and risk factors for Rifater

Healthcare Provider Resources

Symptoms of Rifater

Causes & Risk Factors for Rifater

Diagnostic studies for Rifater

Treatment of Rifater

Continuing Medical Education (CME)

CME Programs on Rifater

International

Rifater en Espanol

Rifater en Francais

Business

Rifater in the Marketplace

Patents on Rifater

Experimental / Informatics

List of terms related to Rifater

Rifater® is a fixed dose combination tablet manufactured by Aventis used in the treatment of tuberculosis. Each tablet contains 120 mg rifampicin, 50 mg isoniazid and 300 mg pyrazinamide.

It is used in the first two months of tuberculosis treatment. The dose given depends on the patient's weight:

* up to 40 kg, 3 tablets daily;
* 40 to 49 kg, 4 tablets daily;
* 50 to 64 kg, 5 tablets daily;
* 65 kg or more, 6 tablets daily.

Rifater should not be used in children (the doses are wrong for them).

The purpose of the fixed dose combination is to make it easier for patients to take their medication; but also to ensure that if patients forget to take one or two of their drugs, they do not then develop resistance to the remaining drugs.

## See also[edit | edit source]

* Tuberculosis treatment
* Rifinah

Template:WH Template:WS